PERSIST: A multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (SOX) with or without sintilimab in resectable locally advanced gastric/gastroesophageal junction cancer (GC/GEJC).
暂无分享,去创建一个
H. Liang | Ru-peng Zhang | L. Shang | Qun Zhao | Honghai Guo | Jingyu Deng | Xue-wei Ding | J. Chai | Yong Liu | Liangliang Wu | Bao-gui Wang | B. Ke | Mingzhi Cai | Xue-jun Wang | Leping Li | Ning Liu | Wen-Feng Huang | Longgang Wang | Bin Li | Jiancheng Zhang